However, the impairment of c.38G >A (p.Gly13Asp) in the KRAS gene and the co-expressed FIP1L1–RARA fusion APL is not completely clear, further studies have to be performed in the future. This evidence concerns the gene FIP1L1 and acute promyelocytic leukemia.